Patents by Inventor Javier Angulo Frutos

Javier Angulo Frutos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator
    Publication number: 20070032471
    Abstract: The present invention relates to an active substance combination comprising at least one 2,5-dihydroxybenzenesulfonic compound and at least one K+ channel modulator, a medicament comprising said active substance combination, a pharmaceutical formulation comprising said active substance combination and the use of said active substance combination for the manufacture of a medicament.
    Type: Application
    Filed: July 29, 2004
    Publication date: February 8, 2007
    Applicant: LABORATORIOS DEL DR. ESTEVE S.A.
    Inventors: Antoni Torrens Jover, Ines Alvarez Mathieu, Inigo Saenz De Tejada Gorman, Javier Angulo Frutos, Helmut-Heinrich Buschmann
  • Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function
    Publication number: 20070010581
    Abstract: The present invention relates to the use of 2,5-dihydroxybenzenesulfonic compounds for the manufacture of medicament for the regulation of nitric oxide (NO) synthesis and/or the regulation of EDHF (Endothelium-derived-Hyperpolarizing-Factor) in the endothelium of humans or animals, whereby the medicament is administered in a daily dose of the 2,5-dihydroxybenzenesulfonic compounds of formula I of <500 mg.
    Type: Application
    Filed: November 29, 2003
    Publication date: January 11, 2007
    Inventors: Jose Esteve-Soler, Inigo Saenz De Tejada-Gorman, Javier Angulo-Frutos
  • Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function
    Publication number: 20060135611
    Abstract: The present invention relates to the use of 2,5-dihydroxybenzenesulfonic compounds for the manufacture of a medicament for the regulation of nitric oxide (NO) synthesis and/or the regulation of EDHF (Endothelium-Derived-Hyperpolarizing-Factor) in the endothelium of diabetic patients, whereby the medicament is administered in a daily dose of the 2,5-dihydroxybenzenesulfonic compounds of formula (I) of <500 mg.
    Type: Application
    Filed: November 29, 2003
    Publication date: June 22, 2006
    Inventors: Jose Esteve-Soler, Inigo Saenz De Tejada-Gorman, Javier Angulo-Frutos